Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
2.520
+0.050 (2.02%)
Nov 21, 2024, 3:04 PM EST - Market open
Purple Biotech Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 5 | 22 | 27 | 68 | 67 | 14 | |
| Market Cap Growth | -59.79% | -19.26% | -60.76% | 1.95% | 364.70% | 30.76% | |
| Enterprise Value | -1 | 5 | -6 | 22 | -0 | 7 | |
| Last Close Price | 2.47 | 15.60 | 27.60 | 77.80 | 76.20 | 155.92 | |
| PB Ratio | 0.32 | 0.63 | 0.57 | 1.05 | 0.84 | 1.33 | |
| P/TBV Ratio | 6.03 | 3.52 | 1.02 | 1.54 | 1.14 | 3.40 | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | |
| Quick Ratio | 1.15 | 2.15 | 4.55 | 11.11 | 18.82 | 1.66 | |
| Current Ratio | 1.27 | 2.20 | 4.71 | 11.41 | 19.14 | 2.34 | |
| Return on Equity (ROE) | -34.39% | -49.09% | -38.79% | -24.61% | -63.35% | -49.47% | |
| Return on Assets (ROA) | -24.97% | -28.14% | -22.50% | -14.55% | -16.74% | -26.81% | |
| Return on Capital (ROIC) | -29.18% | -33.84% | -24.75% | -15.29% | -17.98% | -35.74% | |
| Earnings Yield | -229.29% | -91.76% | -80.75% | -26.88% | -41.74% | -40.53% | |
| FCF Yield | -340.94% | -91.98% | -62.47% | -22.47% | -18.26% | -38.74% | |
| Buyback Yield / Dilution | -22.41% | -2.92% | -52.76% | -493.78% | -36.34% | |
| Total Shareholder Return | -22.41% | -2.92% | -52.76% | -493.78% | -36.34% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.